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Abstract 
Prolonged central nervous system (CNS) inflammation is a problem because it can cause 
behavioral and neurological complications including depression and cognitive dysfunction. After 
a peripheral immune stimulus microglia, the innate immune cells of the CNS, become activated 
and release pro-inflammatory cytokines. Regulation of microglia by anti-inflammatory cytokines 
including interleukin (IL)-4, IL-10, and transforming growth factor beta (TGFβ) may be 
necessary to transition to a less inflammatory repair phenotype. In normal aging, however, this 
process may be impaired as microglia from aged animals have a prolonged and exaggerated 
inflammatory response and are resistant to anti-inflammatory feedback. This impairment of 
microglia regulation may explain the comorbidity of depression and cognitive problems with 
peripheral illnesses and injury in elderly people. To identify how these regulatory processes can 
become impaired with age, we first wanted to establish the extent to which activated microglia 
from adult mice are sensitive to IL-4, IL-10, and TGFβ. We report that activation of microglia in 
vivo with lipopolysaccharide (LPS), a component of gram negative bacteria cell wall, increased 
the expression of IL-4 receptor (IL-4Rα), but not IL-10 receptor (IL-10R1) on the surface of 
microglia. IL-4 and TGFβ decreased inflammatory cytokine expression and increased anti-
inflammatory cytokine expression in vitro but IL-10 had no such effect. In adult ex vivo cultures, 
TGFβ decreased production of IL-1β and increased production of IL-4Rα; IL-4 treatment 
decreased inducible nitric oxide synthase (iNOS) and increased arginase expression. In aged ex 
vivo cultures, TGFβ had no significant effect on IL-1β, CX3CR1, and IL-4Rα expression; IL-4 
treatment increased IL-1β, had no effect on iNOS, and increased arginase expression. 
Preliminary data from intracranioventricular (ICV) injection of a TGFβ inhibitor following 
intraperitoneal (i.p.) LPS injection show a significant lack of social exploratory behavior at 24 h  
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and a tendency towards higher expression of IL-1β and IL-6 from brain slice mRNA. Expression 
of IL-4Rα and IL-10R1 on microglia from LPS-injected adult BALB/c mice was determined by 
flow cytometry. BV2 cells, a mouse microglia cell line, were treated with IL-4, IL-10, or TGFβ 
in the presence or absence of LPS and mRNA levels were determined using qPCR. Primary 
microglia cultures established from neonatal mice were treated with TGFβ and LPS and mRNA 
was analyzed using qPCR. Ex vivo cultures were established from adult or aged BALB/c mice 
microglia that were LPS-activated in vivo; mRNA was analyzed using qPCR. These findings 
indicate that IL-4 and TGFβ are more potent anti-inflammatory mediators for microglia than IL-
10. IL-4 and TGFβ treatment redirects activated microglia towards a less inflammatory 
phenotype. In aged microglia, however, there is an incomplete resolution of inflammation with 
IL-4 or TGFβ treatment. 
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1. Introduction 
1.1. Microglia 
Microglia are the innate immune cells in the CNS and account for approximately 12% of 
cells in the brain. Primitive macrophage precursors from the embryonic yolk sac infiltrate the 
brain and differentiate into microglia (Schwarz et al., 2012). Microglia serve as the resident 
macrophages of the brain but they differ from peripheral macrophages in that microglia have a 
slower turnover rate, express little to no MHC in a resting state, and are more tightly regulated 
spatially and temporally. This regulation of microglia is necessary for a coordinated immune 
response (Aloisi, 2001).Thus, microglia act as the first line of immune defense in the brain and 
spinal cord. Without an immune stimulus, resting microglia survey the microenvironment. 
Conversely, microglia function to phagocytose, present antigens, and propagate inflammatory 
signals upon activation from immune and/or inflammatory stimuli. During activation, microglia 
exhibit an M1 or inflammatory phenotype and transition to an M2 or reparative phenotype. 
Regulation of microglia by anti-inflammatory cytokines may be necessary to transition to a 
repair phenotype. In normal non-diseased states, inflammation associated with microglia 
activation is transient and dissipates with the resolution of the immune stimulus. Thus, microglia 
propagate cytokine signals to regulate the microenvironment in the CNS. 
 
1.2. Cytokines in the CNS 
Cytokines are small polypeptide cell-signaling molecules that exhibit an immunomodulatory 
function. They have an important presence in the CNS because they are both secreted by and 
have effects on microglia. Key cytokines in the CNS that complete a role in microglia regulation  
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include anti-inflammatory mediators interleukin (IL)-4, IL-10, transforming growth factor beta 
(TGFβ) and pro-inflammatory cytokines IL-1β, IL-6, tumor necrosis factor alpha (TNFα) as well 
as the chemokine receptor CX3CR1. When microglia are activated, they produce pro-
inflammatory IL-1β, IL-6, and TNFα. These cytokines stimulate and sustain adaptive sickness 
behaviors including reduced food intake, lethargy, and social withdrawal. Sickness behaviors 
conserve an organism’s energy for production of heat in fever and ultimately aid in the resolution 
of the infection (Dantzer, 2001). In normal non-diseased states, this transient up-regulation of 
inflammatory cytokines is beneficial to the organism. When modulation of inflammatory 
cytokines is misregulated, however, certain CNS complications can occur including cognitive 
impairments, amplified and prolonged sickness behavior, depressive-like behavior, and 
mechanisms that may contribute to neurodegeneration (Perry et al., 2003). 
 Furthermore, regulation of inflammation by anti-inflammatory cytokines may be 
necessary in transitioning microglia to a repair phenotype. IL-4, IL-10, and TGFβ are potent anti-
inflammatory cytokines that have several functions including inhibiting cytokine synthesis, 
reducing macrophage activation, and promoting neuroprotection (Male et al., 2006; Spitzbarth et 
al., 2012). These anti-inflammatory cytokines may have the potential to redirect activated or 
primed microglia to a reparative M2 phenotype. Therefore, the purpose of this study was to 
determine the degree to which activated microglia from adult and aged mice were sensitive to the 
anti-inflammatory effects of IL-4, IL-10, and TGFβ. 
 
1.3. Neuroinflammation and aging 
Although inflammation modulated by adult microglia is transient, normal aging may  
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contribute to an exaggerated and prolonged inflammatory profile. Microglia in the aged brain 
may be “primed” or “reactive” to immune stimuli, express a number of M1 inflammatory 
markers, and exhibit de-ramified morphology (Choi et al., 2007). Following a peripheral immune 
stimulus, these primed microglia produce an exaggerated and prolonged inflammatory response 
which can produce CNS complications including cognitive impairments, exaggerated and 
prolonged sickness behavior, and depressive-like behavior (Barrientos et al., 2006; Abraham et 
al., 2008; Godbout et al., 2008; Godbout et al., 2005b). This amplified and extended 
inflammatory response propagated by primed microglia may explain the comorbidity of 
depression and cognitive problems with peripheral illnesses and injury in the elderly compared to 
their adult counterparts. As such, the regulation of aged microglia by anti-inflammatory 
cytokines is of great interest and is the focus of this thesis. 
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2. Methods and Materials 
2.1. Animals 
Adult (3-4 months old) male BALB/c mice were obtained from a breeding colony kept in 
barrier-reared conditions in a specific-pathogen-free facility at the Ohio State University. Mice 
were individually housed in polypropylene cages and maintained at 25  C under a 12 h light/12 h 
dark cycle with ad libitum access to water and rodent chow. For age comparison, male BALB/c 
mice (18–22 mo) were purchased from the National Institute on Aging Specific-Pathogen-Free 
Colony (maintained at Charles River Laboratories, Inc., MA). The median lifespan for BALB/c 
mice is approximately 26 months (Miller et al., 2005). Aged mice were acclimated to the 
facilities for one week prior to experimentation. To investigate changes that occur from 
adulthood to what is considered aged, 3-4 month-old (adult) and 18-22 month-old (aged) male 
BALB/c mice were used. Upon arrival, mice were individually housed as described above. All 
procedures were in accordance with the National Institute of Health Guidelines for the Care and 
Use of Laboratory Animals and were approved by The Ohio State University Institutional 
Laboratory Animal Care and Use Committee. 
 
2.2. BV2 cell culture and treatment 
BV2 cells were cultured in DMEM (Dulbecco’s modified eagle medium) growth medium 
supplemented with 10% fetal bovine serum (FBS), 3.7 g/L sodium bicarbonate, 200 mM 
glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, as previously described (Wynne et al., 
2010). Cultures were maintained and incubated at 37  C with 95% humidity and 5% CO2 and 
growth medium was replenished every third day until confluence. Before the experiments, cells 
were plated at 1 x 10
5
 cells/well in 24-well plates and allowed to adhere for 20 h. Immediately  
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before treatment, cells were washed twice with serum-free DMEM and supplemented with warm 
serum-free DMEM containing experimental treatments. Following treatment and incubation, 
cells were homogenized and RNA was isolated. For this study, cells were treated with saline or 
LPS (100 ng/ml), then 1 h later treated with either vehicle (0.1% bovine serum albumin [BSA]), 
IL-4 (20 ng/ml), IL-10 (10 ng/ml), or TGF(1 ng/ml) and incubated for 3 h. 
 
2.3. Primary microglia treatment and culture 
Microglia cultures were established from neonatal mice as previously described (Godbout et 
al., 2004). In brief, whole brains were aseptically removed and mechanically dissociated after a 
15 min trypsinization (0.25% trypsin) and passed through a 70 μm nylon mesh, washed twice in 
PBS, and plated on poly-L-lysine coated 162 cm
2
 culture flasks in DMEM growth medium 
supplemented with 20% FBS, 3.7 g/l sodium bicarbonate, 200 mM glutamine, 100 U/ml 
penicillin, 100 μg/ml streptomycin, 50 μg/ml gentamicin. Mixed glia cultures were maintained at 
37  C with 95% humidity and 5% CO2 and growth medium was replenished every third day until 
confluence. Mixed glia cultures were shaken at 120 rev/min and 37  C for 3.5 h to harvest 
microglia from the confluent cell layer. Cells were collected, counted by trypan blue staining on 
a hemocytometer, and plated at a density of 1 x 10
5
 cells/well per 500 μl on poly-L-lysine coated 
24-well plates. After 48 h, microglia were washed twice with serum-free DMEM medium 
(growth medium without FBS) and supplemented with warm serum-free DMEM containing 
experimental treatments. For this thesis, cells were treated with saline or LPS (10 ng/ml) for 1 h, 
then treated with either vehicle (0.1% BSA) or TGF (1 ng/ml). 
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2.4. Ex vivo treatment and culture 
Enriched microglia were washed with PBS and counted by hemocytometer. Cells from each 
animal were then plated at 1 x 10
5 
cells/well into two wells of a poly-L-lysine coated 24-well
 
plate in serum-free DMEM medium. Cells were incubated at
 
37  C with 95% humidity and 5% 
CO2 and allowed to adhere for
 
1 h before experimental treatments. After treatment and 
incubation, cells were homogenized and RNA was isolated. For this report, adult (3-6 mo) and 
aged (18-22 mo) BALB/c mice were euthanized 4 h after i.p. LPS (0.33 mg/kg). The isolated 
enriched microglia were treated with either vehicle (0.1% BSA), IL-4 (20 ng/ml), or TGF(1 
ng/ml) for 3 h. 
 
2.5. Microglia isolation 
Microglia were isolated from whole brain homogenates as described previously (Henry et al., 
2009). In brief, brains were homogenized in phosphate buffer solution (PBS, pH 7.4) and passed 
through a 70 μm nylon cell strainer. Resulting homogenates were centrifuged at 600 g for 6 min. 
Supernatants were removed and cell pellets were re-suspended in 70% isotonic Percoll (GE-
healthcare, Uppsala, Sweden) at room temperature. A discontinuous Percoll density gradient was 
layered as follows: 70%, 50%, 35%, and 0% isotonic Percoll. The gradient was centrifuged for 
20 minutes at 2000 g and microglia were collected from the interface between the 70% and 50% 
Percoll layers (Frank et al., 2006b). Cells were washed and then re-suspended in sterile PBS. The 
number of viable cells was determined using a hemocytometer and 0.1% Trypan blue staining. 
Each brain extraction yielded approximately 3 x 10
5 
viable cells. The Godbout lab has previously 
characterized these cells as approximately 85% CD11b+/CD45
low
 microglia with less than 1% 
CD11b+/CD45
high
 macrophages (Henry et al., 2009). These relative percentages of cells do not 
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change with age or LPS (Henry et al., 2009). Based on this previous characterization, cells 
isolated by Percoll density separation are referred to as “enriched microglia”. 
 
2.6. RNA isolation and qPCR 
RNA was isolated from BV2 cells, primary microglia, a coronal brain slice, or enriched 
microglia. For the BV2 cells, coronal brain slice, and primary microglia, total RNA was isolated 
using the Tri-Reagent protocol (Sigma, MO). For enriched microglia, RNA was isolated using 
the PrepEase kit (USB, OH). In all RNA isolation procedures, RNA concentration was 
determined by spectrophotometry and RNA was reverse transcribed to cDNA. Quantitative 
polymerase chain reaction (qPCR) was performed using the Applied Biosystems (Foster, CA) 
Taqman gene expression assay as previously described (Godbout et al., 2005b). In brief, cDNA 
was amplified by real time PCR where a target cDNA and a reference cDNA (glyceralde-hyde-3-
phosphate dehydrogenase [GAPDH]) were amplified simultaneously using an oligonucleotide 
probe with a 5’ fluorescent reporter dye (6-FAM) and a 3’ quencher dye (NFQ). Fluorescence 
was determined on an ABI PRISM 7300 sequence detection system (Applied Biosystems, CA). 
Data were analyzed using the comparative threshold cycle (Ct) method and results are expressed 
as fold difference from saline controls. In the microglia ex vivo cultures established from the 
brains of adult or aged mice, fold change results are expressed as fold change from the age-
matched saline controls. 
 
2.7. Cannulation surgeries and intracranioventricular injections 
The intracranioventricular (ICV) cannulation was performed as previously described with a  
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few modifications (Godbout et al., 2005a). In brief, mice were deeply anesthetized using 
ketamine and xylazine (100 mg and 10 mg/kg BW i.p., respectively) and the surgical site was 
shaved and sterilized. Mice were positioned in a stereotaxic instrument so that the plane formed 
by the frontal and parietal bones was parallel to the table top. An incision, 1.5 cm in length, was 
made on the cranium to reveal bregma and a 26-guage stainless-steel guide cannula was placed 
in the lateral cerebral ventricle using the following stereotaxic coordinates: lateral 1.2 mm, 
anterior-posterior 0.5 mm to bregma, and 2mm from the dura mater. Two anchoring cranial 
screws were inserted adjacent to the cannula and the cannula was secured with cranioplastic 
cement. A dummy cannula was inserted in the guide cannula to prevent occlusion and infection. 
Mice were injected subcutaneously with Buprinex (111 g/kg BW) following surgery. Mice were 
provided a minimum of 7 d to recover before any treatment was administered. For ICV injection 
into the lateral ventricle, the cannula was connected with sterile tubing to a Hamilton syringe and 
injections were administered using a KS Scientific precision syringe pump. Vehicle (50/50 
PBS/DMSO) or TGFβ inhibitor (SB 431542, Sigma Aldrich, St. Louis, MI) was injected ICV 
into the lateral ventricle at a dose of 2.5 nmoles in 2 μl at a rate of 1 μl/min. 
 
2.8. Flow cytometry 
Enriched microglia were assayed for surface antigens by flow cytometry as previously 
described (Henry et al., 2008, 2009). In brief, Fc receptors were blocked with anti-CD16/CD32 
antibody. Next, enriched microglia were split for staining using two separate panels of 
antibodies. Cells for Panel 1 were incubated with rat anti-mouse antibodies (eBioscience, CA): 
CD11b-APC, CD45-PerCP-Cy5.5, and IL-10R1-PE. Cells for Panel 2 were incubated with rat  
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anti-mouse antibodies (eBioscience, CA): CD11b-APC, CD45-PerCP-Cy5.5, and IL-4Ra-PE. 
Expression of these surface receptors was determined using a Becton-Dickinson FACSCaliber 
four color cytometer. Twenty thousand events were recorded and microglia were identified by 
CD11b+/CD45
low
 expression (Wohleb et al.,2011). For each antibody, gating was determined 
based on appropriate negative isotype stained controls. In age comparisons of IL-4Rα, separate 
isotypes were used for adult and aged mice to control for the increased non-specific staining 
detected in microglia from aged mice. Flow data were analyzed using FlowJo software (Tree 
Star, San Carlos, CA). 
 
2.9. Social exploratory behavior 
To assess the motivation to engage in social exploratory behavior, a novel juvenile was 
introduced into the test mouse’s home cage for a 10 min period at 0 h, 4 h, 8 h, and 24 h post 
LPS. Behavior was videotaped and the time the test mouse engaged in social investigation was 
determined from the video records by a trained observer who was blind to the experimental 
treatments. Baseline social behavior was measured at 0 h for all experimental treatments. Social 
behavior was determined as the amount of time that the experimental subject spent investigating 
the juvenile. Results are expressed as percent of baseline (0 h) social behavior. 
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3. Results 
3.1. IL-4 treatment down-regulated M1-related genes and up-regulated M2-related genes in 
BV2 microglia (IL-4 in BV2, poster 1 fig 2a) (IL-10 BV2, poster 1, fig 2b) 
Activated BV2 microglia cultures were treated with IL-4 to understand its effects on the 
inflammatory profile of microglia in vitro. In activated BV2 microglia, IL-4 treatment 
significantly decreased the expression of inflammatory markers iNOS and IL-1β (p < 0.0001 for 
each) and increased anti-inflammatory markers arginase and suppressor of cytokine signaling 1 
(SOCS1) (p < 0.02). In this experiment, arginase and SOCS1 were strongly induced at 30-fold 
up-regulation in arginase and 90-fold increase in SOCS1 production (figure 1). These results 
show that IL-4 is able to resolve inflammation and transition activated microglia to an M2 
phenotype. 
 
3.2. TGFβ decreases inflammatory cytokine expression in activated BV2 and primary 
microglia 
To understand the effects of TGFtreatment on LPS-activated BV2 and primary microglia, 
the mRNA expression of a panel of anti- and pro-inflammatory cytokines and receptors was 
analyzed. CX3CR1 and IL-4Rwere chosen as anti-inflammatory markers; IL-1, IL-6, and 
TNF were selected as markers of inflammation. TGFtreatment on LPS-activated BV2 
microglia significantly up-regulated CX3CR1 (p < 0.0001), trended to increase IL-4R (p < 0.1), 
and decreased IL-1, IL-6, and TNF (p < 0.001 for each) (figure 2a). In the activated primary 
microglia mRNA profile, TGF treatment significantly increased CX3CR1 (p < 0.0001) and IL- 
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4R(p < 0.001), and decreased expression of IL-1(p < 0.0001) and IL-6 (p < 0.005) (figure 
2b). 
 
3.3. IL-10 failed to fully promote an M2 profile in activated BV2 microglia 
Activated BV2 microglia were treated with IL-10 to understand its effect on several markers 
of inflammation. IL-10 treatment of activated BV2 microglia increased iNOS expression (p < 
0.04), had no effect on IL-1β and arginase, and increased SOCS3 mRNA (p < 0.02) (figure 3). 
Although the anti-inflammatory marker SOCS3 was increased  8-fold, it was not increased to the 
extent to which IL-4 treatment increased SOCS1 (90-fold). These results show that IL-4 and 
TGFβ may be more potent anti-inflammatory mediators than IL-10 on activated microglia. 
 
3.4. Peripheral LPS injection increased surface expression of IL-4Rα, but not IL-10R1, on 
adult microglia 
After determining that IL-4 had more potent effects on the inflammatory profile of activated 
microglia than IL-10, the surface expression of IL-4 receptor (IL-4Rα) and IL-10 receptor (IL-
10R1) on LPS-activated mouse microglia was analyzed by flow cytometry. Both 4 h and 24 h 
after LPS treatment, enriched microglia significantly increased IL-4Rα surface expression (main 
effect of LPS, p < 0.0001 at 4 h, p < 0.003 at 24 h). IL-10R1 expression, however, was 
unchanged compared to saline controls 4h and 24 h post LPS (figure 4). This difference in 
expression of receptors may explain why IL-4 treatment showed a more potent anti-
inflammatory effect on activated microglia compared to IL-10 treatment. 
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3.5. Ex vivo IL-4 treatment lowered inflammation in adult, but not aged, microglia  
To investigate the extent to which inflammation is regulated in adult and aged microglia,  
enriched microglia were treated ex vivo with IL-4 and mRNA was analyzed using qPCR. IL-4 
treatment ex vivo on adult enriched microglia had no effect on IL-1β, increased arginase (p < 
0.01), and decreased expression of iNOS (p < 0.0002) (figure 5). Aged enriched microglia, 
however, exhibited an incomplete resolution of inflammation with IL-4 treatment. In aged mice 
microglia, IL-4 treatment had no effect on iNOS, increased IL-1β expression (p < 0.05), and 
increased arginase (p < 0.003) (figure 5). Although ex vivo IL-4 treatment on aged microglia has 
some anti-inflammatory effect with increased arginase, it does not produce the same reduction in 
inflammatory markers seen in adult ex vivo cultures.  
 
3.6. Peripheral LPS injection increased surface expression of IL-4Rα on adult, but not 
aged, microglia 
After establishing the anti-inflammatory effects of IL-4 in adult and aged activated microglia, 
it was necessary to investigate the expression of IL-4Rα. Therefore, the expression of IL-4Rα on 
the surface of adult and aged mouse microglia was analyzed using flow cytometry. Enriched 
microglia from adult mice showed a significant increase in IL-4Rα expression (p < 0.0001) in 
adult mice 4 h and 24 h after peripheral LPS injection. This increase, however, was absent in 
enriched microglia of aged mice both 4 h and 24 h post LPS (figure 6). This absence in IL-4Rα 
expression on the surface of aged microglia may explain how IL-4 treatment presents an 
incomplete resolution of inflammation in aged microglia compared to adults. 
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3.7. Resolution of inflammation is incomplete in aged microglia with TGFtreatment  
After the effects of TGFtreatment were determined in vitro, the effects of TGFtreatment 
ex vivo were examined by analyzing mRNA expression of anti- and pro-inflammatory markers in 
adult and aged LPS-activated enriched microglia. In adult microglia, TGFtreatment alone 
significantly increased CX3CR1 (p < 0.01) and IL-4R(0.001), and decreased IL-1 mRNA 
expression (p < 0.01). In addition, adult LPS-activated microglia trended to up-regulate IL-
4R(p < 0.2) and trended to down-regulated IL-1(p < 0.1)(figure 7). Ex vivo TGFβ treatment 
on aged enriched microglia, however, had no significant effect on CX3CR1, IL-1β, and IL-4Rα 
(figure 7). These results show that aged microglia do not resolve inflammation compared to their 
adult counterparts. 
 
3.8. TGFβ inhibition may cause prolonged inflammation3) 
To understand the basal effect of TGFβ, adult mice were treated ICV with a TGFβ inhibitor 
following i.p. LPS injection. It is worth noting that this experiment is preliminary and another 
repeat is in preparation. Mice treated with both LPS and TGFβ inhibitor displayed social 
exploratory behavior at 50% of baseline 24 h after LPS (p < 0.03). This is significantly lower 
than all other experimental groups that established approximately 100% of baseline at the same 
time point (figure 8a). Analysis of brain slice mRNA showed a tendency increased IL-1β, IL-6, 
and TNFα expression (p < 0.2 for each) and a significant decrease in CX3CR1 (p < 0.03) in LPS-
and TGFβ inhibitor-treated mice (figure 8b). Microglia-specific mRNA analysis showed a 
tendency of increased CX3CR1 (p < 0.09) and IL-1β (p < 0.1) (figure 8c). These preliminary 
results suggest that TGFβ may be important in hindering inflammatory cytokine expression that  
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correlates with sickness behavior. 
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4. Discussion 
Microglia are the innate immune cell in the CNS and serve to respond to infection and other 
immune stimuli. Upon activation by immune stimuli, microglia release pro-inflammatory 
cytokines to regulate an adaptive sickness response. Regulation of microglia by anti-
inflammatory cytokines may be necessary for the transition to a reparative M2 phenotype. Aged 
microglia, however, exhibit a more inflammatory phenotype characterized by exaggerated and 
prolonged expression of inflammatory markers and maladaptive sickness behavior. Primed 
microglia in the aged brain may explain the comorbidity of depression and cognitive problems 
with peripheral illnesses and injury in the elderly. Therefore, the regulation of aged microglia is 
of great interest. 
The purpose of this study was to evaluate the extent to which several anti-inflammatory 
cytokines (IL-4, IL-10, and TGFβ) can regulate both adult and aged microglia. To determine 
these effects, a panel of pro- and anti-inflammatory markers was selected. This panel includes 
arginase, CX3CR1, IL-1β, IL-4Rα, IL-6, iNOS, TNFα, SOCS1 and SOCS3. 
This study began by determining the effects of IL-4, IL-10, or TGFβ treatment on activated 
BV2 or primary microglia. The results of these experiments indicate that IL-4 and TGFβ may be 
more potent anti-inflammatory mediators of microglia than IL-10. The discovery that microglia 
are less responsive to IL-10 than IL-4 and TGFβ was surprising considering the anti-
inflammatory nature of IL-10 in the periphery. In addition, flow cytometry analysis showed that 
LPS-activated enriched microglia up-regulated IL-4Rα, but not IL-10R1, at 4 h and 24 h post 
LPS. These data may explain why LPS-activated microglia are less responsive to IL-10 than IL-
4. Following these experiments, the study focused on IL-4 and TGFβ treatments in the context of 
aging. 
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In the aging experiments, adult and aged LPS-activated microglia were treated ex vivo with 
IL-4 or TGFβ. The results of IL-4 treatment on adult microglia show a similar anti-inflammatory 
phenotype as expressed in the IL-4 treated BV2 cultures. One notable difference is that IL-4 
treatment had no significant effect on IL-1β mRNA expression in adult microglia. In addition, 
aged LPS-activated microglia showed a decreased capacity to resolve inflammation compared to 
adults. This unresolved inflammatory state was characterized by increased IL-1β expression, no 
reduction in iNOS expression, and an increase in arginase expression that was significantly less 
than the induction of arginase in adult LPS-activated microglia. Aged microglia were unable to 
properly regulate inflammation with IL-4 treatment compared to adults. To better explain this 
phenomenon, adult and aged LPS-activated microglia expression of IL-4Rα was analyzed using 
flow cytometry. These results showed that there was no induction of IL-4Rα 4 h or 24 h after 
LPS in aged microglia; in comparison, adult microglia up-regulated IL-4Rα expression both 4 h 
and 24 h after LPS. These data may explain the lack of inflammation resolution in aged 
microglia treated ex vivo with IL-4. Moreover, these findings support the notion that aged 
microglia are unresponsive to anti-inflammatory regulation. 
In addition, to further investigate microglia regulation of inflammation in normal aging, adult 
and aged LPS-activated microglia were treated ex vivo with TGFβ. These results show a similar 
anti-inflammatory profile as expressed in the TGFβ treated BV2 and primary cultures. One 
exception is that ex vivo TGFβ treatment had no effect on CX3CR1 expression and this was 
unexpected when considering previous studies that show induction of CX3CR1 with TGFβ 
treatment (Wynne et al., 2010). It is noteworthy, however, that TGFβ inhibitors were unable to 
attenuate the induction of CX3CR1; this may indicate that TGFβ alone is not responsible for 
these effects on CX3CR1 expression. Furthermore, LPS-activated microglia from aged mice did  
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not respond to TGFβ treatment. These results show that activated aged microglia are do not 
respond to IL-4 and TGFβ in the same anti-inflammatory manner that adult microglia respond.  
Additionally, to understand the basal effects of TGFβ, adult mice were injected i.p. with LPS 
then injected ICV with a TGFβ inhibitor. Social exploratory behavior analysis showed that at 24 
h after LPS, the mice treated with LPS and TGFβ inhibitor still maintained social withdrawal 
behavior. This effect was significantly different from mice treated with LPS alone. As such, this 
signifies that TGFβ may be necessary in regulating other cytokines (IL-1β, IL-6, and TNFα) 
responsible for maintaining sickness behavior. Supporting this idea, LPS-activated microglia 
treated with TGFβ inhibitor had a tendency to increase expression of IL-1β; analysis of brain 
slice mRNA from this group showed a tendency for increased expression of IL-1β and IL-6. 
Furthermore, previous studies show increased TGFβ in the brains of adult but not aged mice 24 h 
after LPS (Wynne et al., 2010). Therefore, the results of this TGFβ inhibitor experiment may 
explain the lack of response in aged LPS-activated microglia to TGFβ regulation. 
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Figure Legends 
Figure 1. IL-4 treatment down-regulated M1-related genes and up-regulated M2-related 
genes in BV2 microglia. BV2 cells were seeded 100,000 cells per well on a 24-well plate, pre-
treated with saline or LPS (10 ng/ml) for 1h, and then treated with vehicle (0.1% BSA) or IL-4 
(20 ng/mL) for 3 h. RNA was isolated by TriReagent separation, reverse transcribed to cDNA, 
and used for RT-PCR to determine the expression of M1-related (iNOS, IL-1β) and M2-related 
(arginase, IL-10,SOCS3) genes. Bars represent the mean   SEM. Means with different letters (a, 
b, c, d) are significantly (p   0.05) different from each other. n = 6 
Figure 2. TGFβ decreases inflammatory cytokine expression in activated BV2 and primary 
microglia. BV2 microglia or primary microglia from neonatal mice were treated with saline or 
LPS (100 ng/ml for BV2 cells; 10 ng/ml for primaries). After 1 h, TGFβ (1 ng/ml) or vehicle 
(0.1% BSA) was added and microglia were incubated for an additional 3 h. RNA was collected 
and reverse transcribed to cDNA which was then analyzed using qPCR. Bars represent the mean 
  SEM.  Means with different letters (a, b, c, d) are significantly different (p   0.05) from each 
other.  n = 6 
Figure 3. IL-10 failed to fully promote an M2 profile in activated BV2 microglia. BV2 cells 
were seeded 100,000 cells per well on a 24-well plate, pre-treated with saline or LPS (10 ng/ml) 
for 1h, and then treated with vehicle (0.1% BSA) or IL-10 (10 ng/mL) for 3 h. RNA was isolated 
by TriReagent separation, reverse transcribed to cDNA, and used for RT-PCR to determine the 
expression of M1-related (iNOS, IL-1β) and M2-related (arginase, IL-10, SOCS1) genes. Bars 
represent the mean   SEM. Means with different letters (a, b, c, d) are significantly (p   0.05) 
different from each other. n = 6 
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Figure 4. Peripheral LPS injection increased surface expression of IL-4Rα, but not IL-
10R1, on adult microglia. Adult (3-6 mo) BALB/c mice received an intraperitoneal (i.p.) 
injection of saline or LPS (0.33 mg/kg) and euthanized either 4 h or 24 h later. Microglia were 
isolated by Percoll density gradient and stained for IL-4Rα, IL-10R1 CD45, and CD11b for 
analysis of protein expression by flow cytometry. Microglia were identified as CD11b+/CD45
low
. 
Bars represent the mean   SEM. Means with * are significantly (p   0.05) different from saline 
control. n = 4 
Figure 5. Ex vivo IL-4 treatment lowered inflammation in adult, but not aged, microglia. 
Adult (3-6 mo) and aged (18-22 mo) BALB/c mice were injected i.p. with saline or LPS (0.33 
mg/kg) and euthanized 4 h later. Microglia were isolated by Percoll density gradient, plated for 1 
h, and treated with IL-4 (20 ng/mL). RNA was isolated 3 h later, reverse transcribed to cDNA, 
and used for RT-PCR to determine the expression of IL-1β, iNOS, and arginase. Bars represent 
the mean   SEM. Means with different letters (a, b, c) are significantly (p   0.05) different from 
saline. n = 9 
Figure 6. Peripheral LPS injection increased surface expression of IL-4Rα on adult, but not 
aged, microglia. Adult (3-6 mo) and aged (18-22 mo) BALB/c mice were injected i.p. with 
saline or LPS (0.33 mg/kg) and euthanized either 4 h or 24 h later. Microglia were isolated by 
Percoll density gradient and stained for IL-4Rα, CD45, and CD11b for analysis of protein 
expression by flow cytometry. Microglia were identified as CD11b+/CD45
low
. Bars represent the 
mean ± SEM. Means with * are significantly (p<0.05) different from saline. n = 4 
Figure 7. Resolution of inflammation is incomplete in aged microglia with TGFtreatment. 
Adult (3 mo) and aged (20 mo) mice were injected i.p. with LPS (0.33 mg/kg). After 4 h,  
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microglia were isolated, plated and treated with TGFβ (1 ng/mL) or vehicle (0.1% BSA) for an 
additional 3 h. RNA was collected and reverse transcribed to cDNA which was then analyzed 
using qPCR. Bars represent the mean   SEM.  Means with different letters (a, b, c, d) are 
significantly different (p   0.05) from each other. An asterisk (*) signifies a trend (p   0.10). n = 
5   
Figure 8. TGFβ inhibition may cause prolonged inflammation. Adult BALB/c mice 
underwent surgery to install an injection cannula (bregma -1.2 mm laterally, -0.5 mm caudally). 
1 week later, mice were injected i.p. with LPS (0.33 mg/kg) and after 30 mins ICV injected with 
vehicle (50/50 DMSO/saline) or the TGFβ inhibitor SB431542 (2.5 nmoles). Social exploratory 
behavior was pef formed at 0 h, 4 h, 8 h, and 24 h. After 24 h, microglia were isolated and a 
brain slice was collected. RNA was collected and reverse transcribed to cDNA which was then 
analyzed using qPCR. Bars represent the mean   SEM. Means with different letters (a, b, c, d) 
are significantly different (p   0.05) from each other. An asterisk (*) signifies 0.05   p      
0.2. n = 3 to 8 
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